Lubna Alnatour, Ayham Mahmoud, Ameer Awashra, Jonathan Na, Mohammed Chamsi-Pasha
{"title":"成像盲点:免疫检查点抑制剂诱导的心肌炎伴心脏MRI阴性。","authors":"Lubna Alnatour, Ayham Mahmoud, Ameer Awashra, Jonathan Na, Mohammed Chamsi-Pasha","doi":"10.14797/mdcvj.1597","DOIUrl":null,"url":null,"abstract":"<p><p>Immune checkpoint inhibitor (ICI)-induced myocarditis is rare but carries a high morbidity and mortality rate. While cardiac magnetic resonance imaging (CMR) is the first-line imaging modality to support diagnosis, the need for endomyocardial biopsy is needed in negative CMR cases.</p>","PeriodicalId":39207,"journal":{"name":"Methodist DeBakey cardiovascular journal","volume":"21 1","pages":"44-47"},"PeriodicalIF":0.0000,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12047621/pdf/","citationCount":"0","resultStr":"{\"title\":\"A Blind Spot in Imaging: Immune Checkpoint Inhibitor-Induced Myocarditis with Negative Cardiac MRI.\",\"authors\":\"Lubna Alnatour, Ayham Mahmoud, Ameer Awashra, Jonathan Na, Mohammed Chamsi-Pasha\",\"doi\":\"10.14797/mdcvj.1597\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Immune checkpoint inhibitor (ICI)-induced myocarditis is rare but carries a high morbidity and mortality rate. While cardiac magnetic resonance imaging (CMR) is the first-line imaging modality to support diagnosis, the need for endomyocardial biopsy is needed in negative CMR cases.</p>\",\"PeriodicalId\":39207,\"journal\":{\"name\":\"Methodist DeBakey cardiovascular journal\",\"volume\":\"21 1\",\"pages\":\"44-47\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2025-05-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12047621/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Methodist DeBakey cardiovascular journal\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.14797/mdcvj.1597\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q2\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Methodist DeBakey cardiovascular journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.14797/mdcvj.1597","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"Medicine","Score":null,"Total":0}
A Blind Spot in Imaging: Immune Checkpoint Inhibitor-Induced Myocarditis with Negative Cardiac MRI.
Immune checkpoint inhibitor (ICI)-induced myocarditis is rare but carries a high morbidity and mortality rate. While cardiac magnetic resonance imaging (CMR) is the first-line imaging modality to support diagnosis, the need for endomyocardial biopsy is needed in negative CMR cases.